Davita Inc (NYSE:DVA) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Saturday.

Other analysts also recently issued reports about the company. TheStreet upgraded Davita from a “c+” rating to a “b-” rating in a report on Monday, April 3rd. Zacks Investment Research raised shares of Davita from a “hold” rating to a “buy” rating and set a $77.00 price objective for the company in a research report on Tuesday, April 18th. Jefferies Group LLC set a $70.00 price objective on shares of Davita and gave the company a “buy” rating in a research report on Friday, May 26th. Finally, Goldman Sachs Group, Inc. (The) reissued a “sell” rating and issued a $62.00 price objective on shares of Davita in a research report on Thursday, May 25th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company’s stock. Davita presently has an average rating of “Hold” and an average price target of $69.50.

Shares of Davita (NYSE DVA) traded up 0.59% during midday trading on Friday, hitting $63.42. The stock had a trading volume of 1,060,004 shares. Davita has a 12-month low of $54.50 and a 12-month high of $78.77. The stock has a market cap of $12.34 billion, a P/E ratio of 10.42 and a beta of 0.89. The stock has a 50-day moving average price of $65.13 and a 200-day moving average price of $66.08.

Davita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $0.79 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by $0.03. Davita had a net margin of 13.53% and a return on equity of 36.69%. The company had revenue of $3.70 billion during the quarter, compared to analyst estimates of $3.69 billion. Equities analysts forecast that Davita will post $3.52 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This report was originally published by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States and international copyright laws. The original version of this report can be read at https://www.americanbankingnews.com/2017/07/08/davita-inc-dva-downgraded-by-bidaskclub.html.

In other news, Director Charles Berg sold 8,414 shares of the stock in a transaction dated Tuesday, May 9th. The shares were sold at an average price of $65.80, for a total transaction of $553,641.20. Following the transaction, the director now owns 34,719 shares of the company’s stock, valued at $2,284,510.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William L. Roper sold 12,994 shares of the stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $65.89, for a total transaction of $856,174.66. Following the transaction, the director now directly owns 45,277 shares in the company, valued at approximately $2,983,301.53. The disclosure for this sale can be found here. Insiders have sold 22,702 shares of company stock worth $1,495,492 in the last ninety days. Corporate insiders own 2.10% of the company’s stock.

Several institutional investors have recently modified their holdings of DVA. Pacer Advisors Inc. boosted its position in shares of Davita by 3.0% in the first quarter. Pacer Advisors Inc. now owns 3,422 shares of the company’s stock valued at $233,000 after buying an additional 101 shares during the last quarter. Wetherby Asset Management Inc. boosted its position in shares of Davita by 3.3% in the first quarter. Wetherby Asset Management Inc. now owns 3,224 shares of the company’s stock valued at $219,000 after buying an additional 104 shares during the last quarter. SRS Capital Advisors Inc. boosted its position in shares of Davita by 6.6% in the first quarter. SRS Capital Advisors Inc. now owns 1,966 shares of the company’s stock valued at $133,000 after buying an additional 122 shares during the last quarter. Mycio Wealth Partners LLC boosted its position in shares of Davita by 0.5% in the first quarter. Mycio Wealth Partners LLC now owns 24,581 shares of the company’s stock valued at $1,671,000 after buying an additional 125 shares during the last quarter. Finally, Oppenheimer & Co. Inc. boosted its position in shares of Davita by 0.9% in the first quarter. Oppenheimer & Co. Inc. now owns 18,148 shares of the company’s stock valued at $1,234,000 after buying an additional 158 shares during the last quarter. 81.97% of the stock is currently owned by institutional investors and hedge funds.

Davita Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Analyst Recommendations for Davita (NYSE:DVA)

Receive News & Ratings for Davita Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita Inc and related companies with MarketBeat.com's FREE daily email newsletter.